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Abstract 
While the use of enzymes as biocatalysts to assist in the industrial manufacture of fine chemicals 
and pharmaceuticals  has enormous potential, application is frequently limited by evolution-led 
catalyst traits. The advent of designer biocatalysts, produced by informed selection and mutation 
through recombinant DNA technology, enables production of process-compatible enzymes. 
However, to fully realize the potential of designer enzymes in industrial applications, it will be 
necessary to tailor catalyst properties so that they are optimal not only for a given reaction but 
also in the context of the industrial process in which the enzyme is applied. 
 
 
The past two decades have led to major advances in our understanding of the subtleties of 
protein structure-function interrelationships. Mechanisms of protein stability in aqueous and 
nonaqueous environments1,2, the links between conformational mobility, structural integrity and 
activity3,4, and the complexities of substrate specificity have all succumbed to the onslaught of 
advanced molecular methods, including crystallography5-7, site-specific mutagenesis, gene 
shuffling, and protein evolution8-11. Scientists are now in a position to visualize, if not design, 
catalytic systems that approach the functional "ideal". 
 
The "ideal" catalyst is typically considered by the biochemist in terms of turnover number (kcat) 
or, for a given process, in terms of maximum specificity constant (Acat/KM). However, from a 
bioprocess viewpoint, each bioprocess is constrained by a set of conditions dictated by the 
specific properties of the substrates, products, and the bioconversion reaction. Thus, while for 
any given bioprocess it is clearly possible to specify a set of catalyst properties that would con-
stitute the ideal for that process, only broad generalizations for ideality may otherwise be 
identified. 
 
In this review, we discuss molecular properties of enzymes from a bioprocess viewpoint. A 
paradigm for design based on the ideal process determining the desired features of the catalyst is 
presented. "Ideal" characteristics (generic and process-specific) and methodologies for seeking or 
engineering these are discussed. We then review the extent to which significant changes in 
protein functional properties have been achieved by application of these methods, together with 
issues that require more research and/or development. 
Ideal processes 
Bioprocess engineers develop processes not only against fixed capital and operating expenditure, 
but also rapid, and often, very aggressive timelines. This is particularly the case for 
pharmaceutical products where patent expiry on the product demands a robust and scalable 
process with short development times12. Conventionally, once a synthetic route is fixed and the 
biocatalytic step defined, bioprocess design and operation are centered on the properties of the 
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biocata-lyst. There are two reasons for this. First, biocatalysts are typically characterized by tight 
operational specifications. Second, the biocat-alyst can often represent a significant proportion of 
the process operating costs. Increasingly, with more expensive substrates and improved 
biocatalyst production this contributing proportion is being reduced, and with expansion of the 
range of suitable biocata-lysts, it may become desirable as well as possible to center bioprocess 
design and operation on the reaction properties, rather than the bio-catalyst (see Fig. 1). Thus, 
the conventional paradigm can be reversed and the biocatalyst can be designed to fit the process. 
This alternative approach leads us to ask: what are the ideal properties we would want of a 
"designer" biocatalyst, and how would we identify these ideal properties? 
 
The flexibility to design the biocatalyst to fit the process still carries a number of catalyst-
independent constraints, set by the thermodynamics of the reaction and the properties of 
reactants and products (Table 1). In particular, the water solubility characteristics of the reactants 
and products determine the medium for operation13, and their stability as a function of pH and 
temperature determine the range in which the process must operate. In addition, high product 
concentrations are important in optimizing product recovery. 
 
Under the ideal process paradigm (Fig. 1), preselection of optimal process conditions can 
supersede the constraints of any particular biocatalyst. A range of technologies contributes to the 
preselection process (Fig. 2). Having selected the "ideal" process conditions, a growing range of 




Tm Protein melting (denaturation) temperature, typically determined by physical methods such as 
fluorescence, circular dichroism (CD) or calorimetry. 
Topt Apparent temperature optimum for enzyme activity, for a defined set of reaction conditions. 
kcat Turnover number = maximum number of substrate molecules converted to product per unit 
time per active site; a function of the rate constants for the conversion of enzyme-substrate 
complex to enzyme + product. 
KM  Michaelis constant, representative of the dissociation of the enzyme-substrate complex, 
taken as an indication of substrate binding to the active site. 
k cJKM  Specificity constant; indicates the rate of association of enzyme and substrate and also 
indicates specificity for competing substrates. 
 
Catalyst production 
The key to the process architecture defined in a particular case is whether the catalyst is to be 
used as a whole cell or an isolated enzyme. For the majority of enzyme-catalyzed reactions, use 
of an isolated (immobilized) enzyme is the ideal provided that isolation is simple. However, for 
membrane-bound and/or cofactor-dependent enzymes and/or those that are multiprotein 
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complexes, isolation may not be possible, and here the alternative whole-cell process will prove 
the preferred option. It is beyond the scope of this review to consider in depth the presentation 
of the enzyme within a reaction system and the very important aspects of free versus cell-
encapsulated biocatalysts, but the reader is directed to a number of relevant publications14-16. 
Whether a whole-cell or an isolated-enzyme biocatalyst is required, expression in a rapidly 
growing, robust host is the first requirement. Constitutive, rather than inducible, expression is 
preferred. High levels of expression will minimize the fermentation volume, but may lead to 
inclusion body formation. Developments in host-vector systems, coupled with highly evolved 
fermentation technologies, have resulted in bacterial and fungal fermentations capable of yielding 
recombinant enzymes at levels of upward of 10 g/L, in stark comparison with laboratory-based 
expression of recombinant enzymes, where yields of 10-100 mg/L are frequently reported. In all 
cases, the cost of media imposes a need to minimize fermentation volumes by high levels of 
expression. Protease activities, which can result in substantial loss of biocatalyst yield, also need 




Ideal reactors are those with high space/time yield to reduce the capital costs. A packed bed of 
immobilized enzyme has clear advantages in that the voidage is low: 34% compared with up to 
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over 80-90% for a stirred-tank reactor17. The hydrodynamics of a packed-bed reactor, 
characterized by plug flow, have a number of implications, particularly in the generation of 
concentration gradients of substrate and product. As a consequence, both low enzyme KM and 
substrate inhibition are critical, so as to capitalize on the concentration gradient generated from 
column input to output. 
Similarly, pH adjustment is not possible during a single pass through a packed bed, so it is 
essential that the pH/activity profile for the enzyme is sufficiently broad to accommodate any 
pH changes. Critically, multiphasic mixtures cannot be handled in a packed bed, although a 




The ideal process involves the minimum number of downstream steps. The catalyst must be 
easily recovered (immobilization by retention inside the packed bed is optimal). A bottleneck for 
many current processes is the large volume of water from which the product must be removed, 
necessitating a concentration step before isolation18. 
In the ideal process, the catalyst would withstand concentrations of the product high enough 
to allow a single isolation step without prior product concentration. 
 
Key biocatalyst properties 
Turnover. Considering that the primary objective of any industrial biotransformation process is 
a high degree of substrate conversion to product in the minimum possible time, the turnover of 
an enzyme represents a key factor in the concept of the ideal biocatalyst. As many enzymes have 
evolved for very specific and selective metabolic roles, the intrinsic activity or turnover of native 
enzymes depends fundamentally on the nature and mechanism of the in vivo reaction catalyzed 
and the position of in vivo reaction equilibria with respect to metabolic flux. Thus, a particular 
enzyme may catalyze a desired bioconversion reaction, but with a kcat too low for practical 
application, in which case improvement of the turnover using the novel technologies now  
  






available (e.g., directed evolution, gene shuffling, and combinations of rational and combinatorial 
methods) may be required19. Although turnover characteristics of enzymes typically used in 
bioconversions vary widely, high turnovers are characteristic of most current commercial 
biocatalytic processes. 
 
In an operational biocatalyst, the turnover may be influenced not only by the genetically 
determined functional capacity of the protein, but also by the microenvironment of the enzyme, 
and specifically by the form in which the biocatalyst is formulated and applied. Thus process 
conditions (e.g., the type and use of immobilized enzymes) have considerable influence over the 
maximum achievable turnover exhibited by the biocatalyst. Such chemical modifications 
frequently result in lowering of kcat values, attributed to a range of effects, including variations in 
protein flexibility and allosteric properties (conformational), decreased accessibility to the 
enzyme active site20 (steric), and changes in the enzyme microenvironment by the selective 
attraction or exclusion of water, ions, solutes, and so on21. 
The operating temperature of a biocatalytic process is frequently dictated by factors relating to 
the reaction rather than the catalyst, such as substrate/product solubilities, reagent stabilities, or 
the need to reduce undesirable side reactions. Arrhenius kinetics suggest that the highest feasible 
reaction temperature should be selected, but such selection is always constrained by biocatalyst 
stability.
Fortunately, evolution has provided a relatively wide thermal range of native biocatalysts, and 
enzymes derived from psychrotolerant (cold-active) to hyperthermophilic microorganisms may 
retain high levels of activity and/or stability across a temperature range from below 10°C to 
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around 100°C, as demonstrated for a set of functionally homologous enzymes in Figure 3. 
Where the reaction temperature is dictated by the process components, a priori selection of an 
enzyme from the appropriate thermal group (Fig. 3) may minimize subsequent requirements for 
enhancing either turnover or molecular stability. 
 
The ideal biocatalyst for bioconversions involving organic and hydrophobic substrates would 
exhibit high turnover in organic or aqueous-organic media. Many enzymes remain active and 
stable in organic media, but relatively few exhibit enhanced turnover. Although research using 
native enzymes has provided insight into the effects of solvents and ionic conditions on enzyme 
activity22,23 and control over reaction pathways24, biocatalysts with significantly improved turnover 
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Selectivity. Substrate selectivity and affinity are evolved properties of an enzyme, related 
specifically to its metabolic role. For instance, the substrate range for highly specialized 
mammalian enzymes may be far narrower than that of extracellular fungal enzymes. In certain 
cases, broad substrate specificity is essential, as in the use of prote-olytic and lipolytic enzymes in 
laundry detergents, whereas in the production of most pharmaceuticals and fine chemicals, strict 
substrate selectivity is required to ensure fidelity in the reaction pathway, and viable conversion 
yields.  
Control and optimization of stereoselectivity in synthetic bio-transformations and chiral 
resolutions have been seminal focus areas in biocatalysis in recent years, largely as a result of the 
inefficiency of conventional methods for stereochemical control. Many highly stereoselective 
biocatalysts are already in large-scale industrial use (see Table 3), and novel moleone reaction 
type to another, for example, in the modification of indole-3-glycerophosphate synthase, by a 
combination of rational design and directed evolution, to produce novel phosphoribosyl 
anthranilate isomerase activity25. Substrate selectivity can readily be altered, using molecular or 
reaction engineering methods, to the extent where compounds of very different steric structure 
and chemical nature from the natural substrates can be efficiently converted by the biocatalyst . 
For instance, the D-selectivity of a native hydan-toinase was reversed by mutagenesis and 
selective screening procedures, giving an L-specific enzyme with no equivalent in nature, able to 
catalyze the production of L-methionine26. Gene-shuffling techniques have been used to 
randomly recombine genes from two organisms possessing biphenyl dioxygenase activity, 
yielding a recombinant enzyme capable of oxidative degradation of polychlori-nated biphenyls 
(PCBs) and simple aromatic monomers27. 
 
Molecular stability. Biocatalyst stability is a major concern in virtually all bioprocesses, because 
it may affect process economics at a number of levels. Poor biocatalyst stability will result in 
longer process operations (resulting from decreasing catalytic efficiency), increased frequency of 
catalyst replacement and reduced product yields. The causes of reduced biocatalyst stability are 
intimately associated with the process conditions, and may include extremes of temperature, 
ionic strength, or pH that are outside the operating "stability window" of the catalyst, or the 
presence of denaturants, such as substrates/products, organic solvents, surfaces, or interfaces. 
Some of the options currently available to the bioprocess industry to address the problem of 
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The effect of any deleterious condition on the lifespan of a biocat-alyst is dependent first on the 
intrinsic molecular stability of the protein, and second on the mode of presentation of the 
enzyme in the reactor system (e.g., whether the enzyme is cell-encapsulated, immobilized, or 
crosslinked). Intrinsic molecular stability is a function of both amino acid sequence and tertiary 
(and quaternary) structure and is dictated, at least in part, by the origins of the protein. Studies of 
extremophilic organisms and their enzymes have provided extensive insights into both the outer 
limits of molecular stability and molecular mechanisms responsible for structural stabilization. 
Proteins of extremely high thermal stability (e.g., Tm values of 80°-130°C) are typically isolated 
from hyperthermophilic organisms (growing at up to 115°C), whereas the proteins of 
psychrophilic organisms (growing to well below 0°C) are generally relatively unstable (e.g., Tm 
values of 20°-50°C). While the selection of a hyperther-mophile-derived biocatalyst provides a 
ready means of ensuring high molecular stability, such enzymes have evolved to function 
optimally at near the organism's growth temperature and exhibit reduced catalytic rates if 




Over two decades of intensive study into the mechanisms of protein stability have led both to 
the identification of a range of molecular stabilization mechanisms (e.g., the presence of salt-
bridging networks: see reviews28-30) and to the engineering of increased structural stability by 
random and site-specific mutagenesis, enzyme evolution, and gene shuffling. While small 
increments in enzyme stability are typically achieved by site-specific mutagenesis31, some remark-
able increases (Tm values enhanced by 10°-15°C) have been achieved by directed enzyme 
evolution32,33. Such changes are not always to the detriment of catalytic activity. For example, the 
engineering of a 340-fold increase in stability at 100°C in a Bacillus stearothermophilus protease by 
eight site-specific mutations34 was achieved without compromising catalytic activity, 
contradicting the dogma that molecular stability and activity are reciprocally related (through 
global conformational flexibility). Furthermore, there is good evidence for a general correlation 
between molecular stability to temperature and to other denaturing conditions35,36, suggesting 
common initiators and/or pathways of protein denaturation, whether induced by high  
  







temperature, extremes of pH, or the presence of organic solvents or detergents. The practical 
consequence of this observation is that the selection of a more thermostable enzyme variant 
(e.g., derived from a thermophilic source) or the engineering of enhanced thermostabil-ity may 
also result in increased molecular resistance to a range of deleterious conditions. 
 
Virtually all the industrially significant changes in catalyst stability (e.g., in the evolution of xylose 
isomerases in the glucose conversion/high-fructose syrup industry) have come from strain 
selection, chemical modification (immobilization, chemical crosslinking), classical mutagenesis, 
or random mutagenesis. Of these, chemical modification is still the most widely used technology 
in industry for increasing biocatalyst stability. This preoccupation with traditional technology 
may reflect the simplicity and reliability of the procedures, and their cost-effectiveness in 
comparison with more modern and sophisticated genetic technologies. Recent developments in 
immobilization and related technologies, including cell-surface expression of enzymes37,38, 
multipoint covalent immobilization39, and the application of crosslinked enzyme crystals40, are 
likely to ensure that industrial biocatalysis continues to employ such methods. The last two of 
these methods take advantage of the fact that a restriction of conformational flexibility, as in 
covalent crosslinking or embedding in a crystal lattice, significantly increases the activation 
energy of denaturation and prevents enzyme aggregation. 
  











Whether a process is designed around the catalyst properties, or the catalyst is selected to suit 
process needs, the available range of relevant catalysts is a key issue. The range of enzymes 
potentially available to the bioprocess industry is firstly dictated by evolution, that is, by genetic 
diversity. Although little consensus exists on true genetic diversity (genetic represented as species 
diversity), estimates for plant, animal, and microbial diversity (see Table 5) are in the order of 
107-108 species. With an average of 104-105 open reading frames per genome, many of which 
encode enzymes, the total enzyme genetic diversity may be as great as 1013 distinct functional 
sequences. This figure is, of course, substantially reduced by the varying, often high, homology 
between enzymes from related and even unrelated organisms. 
 
This diversity of closely, distantly, or unrelated sequences represents the core biological resource, 
conceptually considered in terms of "sequence space"41. Native sequence space, representing the 
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diversity of functional (and nonfunctional) protein sequences available from nature, still 
represents a relatively small proportion of total sequence space—theoretically estimated as the 
total number of permutations of 20 amino acids (which is 20100 for a polypeptide of 100 amino 
acids). Only a relatively small proportion of native sequence space is currently available to the 
scientific and bioindustrial community, for the simple reason that a very high proportion of 
extant species have never been investigated, or, even if investigated, are not readily accessible. 
The acknowledged reality that a very high proportion of microbial species are currently 
"unculturable"42 (Table 5) further restricts access to microbial (bacterial, archaeal, fungal, and 
unicellular algal) genomes and gene products. 
 
The rapid development of genetic technologies has provided increasingly inventive methods for 
indirectly accessing new areas of sequence space (Fig. 4). Chemical, site-directed, and random 
muta-genesis technologies access regions proximal to the native sequences, whereas methods, 
such as gene and domain swapping, DNA shuffling, and other forms of combinatorial genomics 
access the regions between the parent sequences. 
 
Modern bioprospecting methods such as multiplex or metagenome cloning43-46 and similar 
methods used by companies such as Diversa Corporation (La Jolla, CA) and TerraGen 
Discovery (Vancouver, BC, Canada) directly access environmental genomes (whether culturable 
or unculturable). These methods access sequence space in a virtually random manner and have 
been successfully employed to isolate novel nahR (ref. 45) and amylase, lipase, and hemolytic 
enzyme genes46. 
Perspective 
If we accept the new paradigm that the design of an optimized process may proceed without 
intimate consideration of the limitations of the biocatalyst, and that technologies are available for 
the subsequent selection or design of the "ideal" catalyst, the following questions are highly 
relevant: First, where are the limiting factors? And second, what more is required to overcome 
the limiting factors? 
 
It is evident from the recent literature that in vitro enzyme evolution technologies are being very 
rapidly assimilated. These offer a relatively fast and inexpensive approach to the incremental 
modification of selected enzyme properties, with a reduced risk that desirable enzyme 
characteristics will be lost in the process. 
 
A major limitation is the monoselective nature of almost all protein-engineering and enzyme-
screening technologies. Single-function screening is essentially incompatible with the 
requirements of the "ideal process" paradigm, in which a defined set of target properties will 
require polyfunctional screening and/or engineering strategies. First attempts at multifunction 
screening have been reported47. 
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However, despite the recent development of sophisticated molecular engineering and screening 





process is still limited. Rational design methods face the greatest limitation in scope. For 
example, despite the intense focus over the past decade on the molecular determinants of protein 
stability, site-specific protein engineering cannot yet be reliably applied to protein stabilization. 
None of the "design rules" for thermostability that have evolved from comparative structural 
studies of more and less stable protein homologs44,48 can be simply employed to indicate site-
specific modifications for reliably enhancing molecular stability. The use of design algorithms for 
predicting multiple additive muta-tions49 may provide a future guide to the engineering of 
hyperther-mostable enzymes. Such algorithms are not currently available for other functional 
characteristics (solvent stability, alterations in specificity, pH behavior, or turnover, for example) 
for which even less generic molecular information is available. Direct (i.e., metage-nomic) 
screening and DNA-shuffling technologies offer the widest access to sequence space. However, 
both are limited by the fact that any single environmental DNA sample is a poor representation 
of the enormous genomic diversity present in the multitude of global biotopes. 
 
So are we ready to implement the ideal process paradigm? We conclude that many of the 
necessary molecular and screening technologies are in place, and there is early evidence of an 
evolution from monofunctional to multifunctional screening. In our opinion, the full 
implementation of the latter is the key to the successful acquisition of new "designer" 
biocatalysts for truly optimized "ideal" bio-processes. 
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